Open AccessNovel Treatment Options in Childhood Bone Diseases
Author(s) -
Sončka Jazbinšek,
Maša Koce,
Primož Kotnik
Publication year - 2022
Publication title -
hormone research in paediatrics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.816
H-Index - 89
eISSN - 1663-2826
pISSN - 1663-2818
DOI - 10.1159/000523868
Subject(s) - medicine , denosumab , discontinuation , rickets , osteoporosis , hypophosphatemia , bisphosphonate , population , vitamin d and neurology , teriparatide , bone mineral , pediatrics , endocrinology , environmental health
Several novel treatment options have recently become available in childhood bone diseases. The purpose of this article is to provide an update on some of the therapeutic agents used in the treatment of pediatric osteoporosis, X-linked hypophosphatemic rickets, and achondroplasia (ACH).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom